BEIJING – Two Chinese biotech companies are forming an alliance to bring a safer and more effective novel treatment for colorectal, breast and ovarian cancer patients in China.
HONG KONG – China is gradually moving toward a new medicine distribution system where pharmacies and external retailers take over sales of prescription drugs from hospitals. The gradual change could ultimately eliminate "commissions" for doctors and hospitals.
BEIJING – A new scheme to improve and boost the development of Shanghai's biopharmaceutical industry that will take effect at the end of this month should generate opportunities for local biopharmaceutical enterprises, especially the bigger ones.
HONG KONG – China is gradually moving toward a new medicine distribution system where pharmacies and external retailers take over sales of prescription drugs from hospitals. The gradual change could ultimately eliminate "commissions" for doctors and hospitals.
BEIJING – Two Chinese biotech companies are forming an alliance to bring a safer and more effective novel treatment for colorectal, breast and ovarian cancer patients in China.
BEIJING – A new scheme to improve and boost the development of Shanghai's biopharmaceutical industry that will take effect at the end of this month should generate opportunities for local biopharmaceutical enterprises, especially the bigger ones.
HONG KONG – A Chinese protein drug developer received a $24 million investment to prepare a new subsidiary and pave the way for an initial public offering (IPO).
HONG KONG – A Chinese pharmaceutical company that went public last month in Hong Kong is expanding its pipeline through a $20 million deal that will bring a novel cancer drug from South Korea to China.
HONG KONG – A Chinese protein drug developer received a $24 million investment to prepare a new subsidiary and pave the way for an initial public offering (IPO).
HONG KONG – A Chinese pharmaceutical company that went public last month in Hong Kong is expanding its pipeline through a $20 million deal that will bring a novel cancer drug from South Korea to China.
